20241216 lab meeting_楷軒
-
00:00
1.
index 1
-
00:01
2.
Identification and characterization of circPOLA2 in NSCLC
-
00:01
3.
Slide 1
-
00:11
4.
Identification and characterization of circPOLA2 in NSCLC
-
03:51
5.
Identification and characterization of circPOLA2 in NSCLC
-
14:16
6.
Correlation between circPOLA2 expression and clinicopathological features
-
14:21
7.
Identification and characterization of circPOLA2 in NSCLC
-
16:16
8.
Correlation between circPOLA2 expression and clinicopathological features
-
25:47
9.
CircPOLA2 suppressed the proliferation and aggressiveness of NSCLC cells
-
29:31
10.
CircPOLA2 suppressed the proliferation and aggressiveness of NSCLC cells
-
32:23
11.
CircPOLA2 sensitized non-small cell lung cancer cells to ferroptosis
-
36:47
12.
CircPOLA2 suppressed the tumorigenesis of NSCLC
-
38:09
13.
CircPOLA2 directly interacted with Merlin
-
41:34
14.
CircPOLA2 directly interacted with Merlin
-
44:44
15.
CircPOLA2 activated the Hippo pathway by inhibiting the phosphorylation of Merlin
-
44:46
16.
CircPOLA2 directly interacted with Merlin
-
50:38
17.
CircPOLA2 activated the Hippo pathway by inhibiting the phosphorylation of Merlin
-
52:13
18.
CircPOLA2 activated the Hippo pathway by inhibiting the phosphorylation of Merlin
-
55:52
19.
CircPOLA2 activated the Hippo pathway by inhibiting the phosphorylation of Merlin
-
56:01
20.
CircPOLA2 sensitized ferroptosis and inhibited tumorigenesis via Merlin
-
56:38
21.
CircPOLA2 sensitized ferroptosis and inhibited tumorigenesis via Merlin
-
58:01
22.
CircPOLA2 sensitized ferroptosis and inhibited tumorigenesis via Merlin
-
59:32
23.
CircPOLA2 sensitized ferroptosis and inhibited tumorigenesis via Merlin
-
1:04:59
24.
** after 20241007.pptx
-
00:00
1.
index 1
-
00:01
2.
Identification and characterization of circPOLA2 in NSCLC
-
00:01
3.
Slide 1
-
00:11
4.
Identification and characterization of circPOLA2 in NSCLC
-
03:51
5.
Identification and characterization of circPOLA2 in NSCLC
-
14:16
6.
Correlation between circPOLA2 expression and clinicopathological features
-
14:21
7.
Identification and characterization of circPOLA2 in NSCLC
-
16:16
8.
Correlation between circPOLA2 expression and clinicopathological features
-
25:47
9.
CircPOLA2 suppressed the proliferation and aggressiveness of NSCLC cells
-
29:31
10.
CircPOLA2 suppressed the proliferation and aggressiveness of NSCLC cells
-
32:23
11.
CircPOLA2 sensitized non-small cell lung cancer cells to ferroptosis
-
36:47
12.
CircPOLA2 suppressed the tumorigenesis of NSCLC
-
38:09
13.
CircPOLA2 directly interacted with Merlin
-
41:34
14.
CircPOLA2 directly interacted with Merlin
-
44:44
15.
CircPOLA2 activated the Hippo pathway by inhibiting the phosphorylation of Merlin
-
44:46
16.
CircPOLA2 directly interacted with Merlin
-
50:38
17.
CircPOLA2 activated the Hippo pathway by inhibiting the phosphorylation of Merlin
-
52:13
18.
CircPOLA2 activated the Hippo pathway by inhibiting the phosphorylation of Merlin
-
55:52
19.
CircPOLA2 activated the Hippo pathway by inhibiting the phosphorylation of Merlin
-
56:01
20.
CircPOLA2 sensitized ferroptosis and inhibited tumorigenesis via Merlin
-
56:38
21.
CircPOLA2 sensitized ferroptosis and inhibited tumorigenesis via Merlin
-
58:01
22.
CircPOLA2 sensitized ferroptosis and inhibited tumorigenesis via Merlin
-
59:32
23.
CircPOLA2 sensitized ferroptosis and inhibited tumorigenesis via Merlin
-
1:04:59
24.
** after 20241007.pptx
- 位置
-
- 資料夾名稱
- 2024
- 發表人
- 黃鈺涵
- 單位
- 賴亮全教授
- 建立
- 2024-10-07 10:29:51
- 最近修訂
- 2024-10-07 10:50:01
- 長度
- 1:05:20